NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2022210040

Registered date:01/10/2021

Pilot study of dMD-002 in patients with neurovascular bundles injury during radical prostatectomy -

Basic Information

Recruitment status Not Recruiting
Health condition(s) or Problem(s) studiedProstate cancer
Date of first enrollment01/10/2021
Target sample size12
Countries of recruitment
Study typeInterventional
Intervention(s)The cut dMD-002 is implanted to cover the nerve injury, tear, or defect, and is fixed by suturing to the surrounding tissue in two or more places.

Outcome(s)

Primary OutcomeEfficacy Change in EHS Change in IIEF EF Change in EPIC sxual function(Q17 to 23) Safety Advere event defect
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum< 75age old
GenderMale
Include criteria(1) Patients diagnosed with prostate cancer (2) Patients scheduled for radical prostatectomy (non-nerve sparing or unilateral nerve-sparing) by robot-assisted laparoscopic surgery etc.
Exclude criteria(1) Patients required radiation therapy, endocrine therapy or antineoplastic therapy before or after radical prostatectomy (2) Patients taking PDE5 inhibitors (3) Patients using negative pressure erection apparatus

Related Information

Contact

Public contact
Name Public relations
Address 7, Yotsuya 1-chome, Shinjuku-ku, Tokyo Tokyo Japan 160-8515
Telephone +81-3-3225-6303
E-mail webmaster@mochida.co.jp
Affiliation Mochida Pharmaceutical Co., Ltd.
Scientific contact
Name Masaki Nakamura
Address 7, Yotsuya 1-chome, Shinjuku-ku, Tokyo 160-8515, Japan Tokyo Japan 160-8515
Telephone +81-3-3225-6306
E-mail dmd001.mdbd@mochida.co.jp
Affiliation Mochida Pharmaceutical Co., Ltd.